Locati LD - Search Results

1

Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma.

van Boxtel W, Locati LD, van Engen-van Grunsven ACH, Bergamini C, Jonker MA, Fiets E, Cavalieri S, Tooten S, Bos E, Quattrone P, Verhaegh GW, Schalken JA, Licitra L, van Herpen CML; PALGA Group. van Boxtel W, et al. Among authors: locati ld. Eur J Cancer. 2019 Mar;110:62-70. doi: 10.1016/j.ejca.2018.12.035. Epub 2019 Feb 13. Eur J Cancer. 2019. PMID: 30771738

2

Primary high-grade mucoepidermoid carcinoma of the minor salivary glands with cutaneous metastases at diagnosis.

Locati LD, Quattrone P, Pizzi N, Fior A, Cantù G, Licitra L. Locati LD, et al. Oral Oncol. 2002 Jun;38(4):401-4. doi: 10.1016/s1368-8375(01)00082-3. Oral Oncol. 2002. PMID: 12076708

3

Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer.

Licitra L, Locati LD, Cavina R, Garassino I, Mattavelli F, Pizzi N, Quattrone P, Valagussa P, Gianni L, Bonadonna G, Solero CL, Cantu G. Licitra L, et al. Among authors: locati ld. Ann Oncol. 2003 Mar;14(3):367-72. doi: 10.1093/annonc/mdg113. Ann Oncol. 2003. PMID: 12598339 Free article. Clinical Trial.

4

Cancer of the larynx.

Licitra L, Bernier J, Grandi C, Locati L, Merlano M, Gatta G, Lefebvre JL. Licitra L, et al. Crit Rev Oncol Hematol. 2003 Jul;47(1):65-80. doi: 10.1016/s1040-8428(03)00017-9. Crit Rev Oncol Hematol. 2003. PMID: 12853099 Review.

5

A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland.

Locati LD, Quattrone P, Bossi P, Marchianò AV, Cantù G, Licitra L. Locati LD, et al. Ann Oncol. 2003 Aug;14(8):1327-8. doi: 10.1093/annonc/mdg331. Ann Oncol. 2003. PMID: 12881399 Free article. No abstract available.

6

Cisplatin and fluorouracil concurrent to radiotherapy in nasopharyngeal cancer: is the schedule compatible?

Licitra L, Bossi P, Locati L, Zunino F. Licitra L, et al. J Clin Oncol. 2004 Jan 15;22(2):377; author reply 377-8. doi: 10.1200/JCO.2004.99.219. J Clin Oncol. 2004. PMID: 14722048 No abstract available.

7

Head and neck tumors other than squamous cell carcinoma.

Licitra L, Locati LD, Bossi P, Cantù G. Licitra L, et al. Among authors: locati ld. Curr Opin Oncol. 2004 May;16(3):236-41. doi: 10.1097/00001622-200405000-00008. Curr Opin Oncol. 2004. PMID: 15069319 Review.

8

Regionally advanced nasopharyngeal carcinoma: long-term outcome after sequential chemotherapy and radiotherapy.

Palazzi M, Guzzo M, Bossi P, Tomatis S, Cerrotta A, Cantú G, Locati LD, Licitra L. Palazzi M, et al. Among authors: locati ld. Tumori. 2004 Jan-Feb;90(1):60-5. doi: 10.1177/030089160409000114. Tumori. 2004. PMID: 15143974 Clinical Trial.

9

Head and neck cancer.

Licitra L, Locati LD, Bossi P. Licitra L, et al. Among authors: locati ld. Ann Oncol. 2004;15 Suppl 4:iv267-73. doi: 10.1093/annonc/mdh937. Ann Oncol. 2004. PMID: 15477319 Free article. Review. No abstract available.

10

Herceptin plus chemotherapy in relapsed and/or metastatic salivary gland cancer.

Locati LD, Rinaldi G, Bossi P, Dagrada GP, Quattrone P, Cantú G, Licitra L. Locati LD, et al. Oral Oncol. 2005 Jan;41(1):97-8. doi: 10.1016/j.oraloncology.2004.03.002. Oral Oncol. 2005. PMID: 15598592 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters